StocksFundsScreenerSectorsWatchlists
PEN

PEN - Penumbra Inc Stock Price, Fair Value and News

208.90USD-1.15 (-0.55%)Market Closed

Market Summary

PEN
USD208.90-1.15
Market Closed
-0.55%

PEN Alerts

  • 1 major insider sales recently.

PEN Stock Price

View Fullscreen

PEN RSI Chart

PEN Valuation

Market Cap

8.1B

Price/Earnings (Trailing)

89.37

Price/Sales (Trailing)

7.68

EV/EBITDA

74.46

Price/Free Cashflow

98.98

PEN Price/Sales (Trailing)

PEN Profitability

Operating Margin

64.49%

EBT Margin

7.52%

Return on Equity

7.71%

Return on Assets

5.84%

Free Cashflow Yield

1.01%

PEN Fundamentals

PEN Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

28.69%

Rev. Growth (Qtr)

5.07%

PEN Earnings

Earnings (TTM)

91.0M

Earnings Growth (Yr)

1.3K%

Earnings Growth (Qtr)

488.43%

Breaking Down PEN Revenue

Last 7 days

-5.8%

Last 30 days

-5.5%

Last 90 days

-18.4%

Trailing 12 Months

-22.8%

How does PEN drawdown profile look like?

PEN Financial Health

Current Ratio

6.06

PEN Investor Care

Shares Dilution (1Y)

1.37%

Diluted EPS (TTM)

2.31

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023884.6M937.8M995.1M1.1B
2022782.3M806.4M829.9M847.1M
2021592.3M671.4M710.5M747.6M
2020556.3M527.2M538.8M560.4M
2019470.7M495.2M522.9M547.4M
2018363.3M392.3M420.2M444.9M
2017278.6M294.1M310.8M333.8M
2016205.1M227.9M244.6M263.3M
2015138.3M149.1M167.1M186.1M
201498.0M107.2M116.3M125.5M
201300088.8M

Tracking the Latest Insider Buys and Sells of Penumbra Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
roberts johanna
sold
-130,242
217
-600
evp, gen. counsel & secretary
Apr 01, 2024
kassing don w.
sold
-37,940
223
-170
-
Mar 15, 2024
roberts johanna
acquired
-
-
2,070
evp, gen. counsel & secretary
Mar 15, 2024
shiu lambert
sold (taxes)
-51,538
222
-232
chief accounting officer
Mar 15, 2024
roberts johanna
sold (taxes)
-41,319
222
-186
evp, gen. counsel & secretary
Mar 15, 2024
shiu lambert
acquired
-
-
1,670
chief accounting officer
Mar 15, 2024
yuen maggie
sold (taxes)
-42,874
222
-193
chief financial officer
Mar 15, 2024
yuen maggie
acquired
-
-
2,070
chief financial officer
Mar 06, 2024
elsesser adam
acquired
38,750
7.75
5,000
ceo and president
Mar 04, 2024
bose arani
sold
-1,876,500
250
-7,500
-

1–10 of 50

Which funds bought or sold PEN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 16, 2024
Financial Management Professionals, Inc.
unchanged
-
-
1,000
-%
Apr 16, 2024
Artemis Investment Management LLP
reduced
-58.99
-363,017
207,482
-%
Apr 16, 2024
MCF Advisors LLC
unchanged
-
-680
5,357
-%
Apr 15, 2024
JANICZEK WEALTH MANAGEMENT, LLC
unchanged
-
-142
1,116
-%
Apr 15, 2024
Sunbelt Securities, Inc.
unchanged
-
-595
4,687
-%
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
added
0.2
-128,873
1,031,980
0.03%
Apr 12, 2024
AdvisorNet Financial, Inc
sold off
-100
-252
-
-%
Apr 11, 2024
CONGRESS ASSET MANAGEMENT CO /MA
added
375
4,523,870
5,931,230
0.04%
Apr 11, 2024
17 CAPITAL PARTNERS, LLC
unchanged
-
-36,329
285,894
0.21%
Apr 11, 2024
Roble, Belko & Company, Inc
unchanged
-
-
1,000
-%

1–10 of 47

Are Funds Buying or Selling PEN?

Are funds buying PEN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PEN
No. of Funds

Unveiling Penumbra Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
price t rowe associates inc /md/
8.0%
3,105,828
SC 13G
Feb 13, 2024
vanguard group inc
9.48%
3,658,102
SC 13G/A
Feb 09, 2024
capital research global investors
6.9%
2,677,789
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 24, 2024
blackrock inc.
10.4%
4,000,277
SC 13G/A
Feb 13, 2023
capital research global investors
6.1%
2,321,719
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
9.13%
3,467,792
SC 13G/A
Jan 23, 2023
blackrock inc.
11.6%
4,422,738
SC 13G/A
Oct 07, 2022
blackrock inc.
10.3%
3,904,542
SC 13G/A

Recent SEC filings of Penumbra Inc

View All Filings
Date Filed Form Type Document
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 01, 2024
144
Notice of Insider Sale Intent
Mar 21, 2024
8-K
Current Report
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 08, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading

Peers (Alternatives to Penumbra Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
183.7B
40.1B
-5.40% 4.53%
32.1
4.58
-8.12% -17.45%
67.1B
19.5B
-2.42% -9.87%
53.41
3.44
4.02% -22.04%
22.6B
3.9B
-2.94% -12.25%
50.69
5.84
3.42% 23.09%
20.1B
14.8B
-4.93% -7.94%
7.56
1.35
2.12% 209.17%
MID-CAP
9.2B
3.5B
-1.69% 15.70%
32.17
2.62
4.97% 18.89%
9.0B
12.3B
-4.49% -14.03%
21.69
0.73
-2.44% -22.68%
8.5B
2.7B
-12.27% -39.23%
-13.34
3.18
-4.68% 82.43%
6.3B
4.0B
-6.21% -24.72%
-46.81
1.59
1.10% 85.84%
3.4B
366.4M
-0.75% 15.36%
-565.58
9.37
33.86% 89.83%
2.3B
6.6B
-5.91% -4.69%
11.86
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-6.61% -18.37%
-1.85
0.39
7.73% -1066.14%
380.0M
166.7M
0.59% -11.05%
-4.6
2.28
6.67% -456.34%
260.4M
324.0M
21.04% -28.41%
-1.35
0.8
-3.19% -337.41%
48.2M
52.3M
-22.35% -53.67%
-2.57
0.92
17.61% 19.28%
3.8M
3.7M
-16.76% 269.23%
-0.31
1.01
5.77% 8.23%

Penumbra Inc News

Latest updates
MarketBeat37 hours ago
Yahoo Movies Canada13 Apr 202403:33 am
Marketscreener.com12 Apr 202401:39 am
Seeking Alpha23 Feb 202408:00 am

Penumbra Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue5.1%284,679270,946261,499241,398221,216213,678208,344203,895204,011190,117184,258169,204166,898151,076105,109137,329145,263139,502134,201128,439120,793
Cost Of Revenue4.8%97,68793,22894,63890,32682,78978,35174,30976,47778,56470,20565,57257,86772,58560,15340,17949,32047,13543,50440,27344,52942,081
Gross Profit5.2%186,992177,718166,861151,072138,427135,327134,035127,418125,447119,912118,686111,33794,31390,92364,93088,00998,12895,99893,92883,91078,712
Operating Expenses-8.0%151,963165,093148,972143,064133,594129,893134,174131,464165,504111,131108,37497,87496,058111,08182,57987,39987,54983,02281,12772,75872,043
  S&GA Expenses3.3%130,021125,920127,435123,078115,630108,573114,615110,900113,50094,39790,63679,79876,60376,15859,85474,45374,68869,28967,66561,09161,176
  R&D Expenses---21,53719,986-21,32019,55920,564-16,73417,73818,076-34,92322,72512,946-13,73313,46211,66710,867
EBITDA Margin33.5%0.10*0.08*0.07*0.05*0.03*-0.02*-0.02*-0.01*0.01*0.06*0.02*-0.02*---------
Income Taxes-492.7%-16,0604,09057690.003,2515,3062,520-5,183-16,321-2491,9041,541-3,143-9,855-4,129-1,6342,4481,963-2,7351,455885
Earnings Before Taxes186.8%38,15813,30419,5368,6527,1283,035-1,167-5,104-40,9547,78210,20312,467-511-19,731-17,030-74611,74912,96313,51411,9097,349
EBT Margin54.0%0.08*0.05*0.04*0.02*0.00*-0.05*-0.05*-0.04*-0.01*0.04*0.00*-0.04*---------
Net Income488.4%54,2189,21418,9608,5623,877-2,271-3,68779.00-24,6338,8509,23111,8363,648-8,815-11,9601,4259,68911,48316,58810,6986,659
Net Income Margin110.5%0.09*0.04*0.03*0.01*0.00*-0.04*-0.02*-0.01*0.01*0.05*0.02*-0.01*---------
Free Cashflow18.6%32,61627,51212,7579,235-2,225-19,257-44,006-9,471-17,36230,648-6,605-18,359---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets6.0%1,5561,4681,4331,3951,3711,3221,3281,3021,244973841823810780664666614585569558501
  Current Assets5.4%915868828786756724718690681668635618590576454463451435423410398
    Cash Equivalents66.2%16710111495.0070.0055.0058.0068.0059.0066.0056.0070.0080.0013472.0073.0011277.0096.0068.0048.00
  Inventory3.7%388374359344334320296274264258245220192183166153140133122116110
  Net PPE10.8%73.0066.0066.0065.0065.0064.0063.0060.0059.0057.0050.0048.0065.0062.0059.0052.0046.0038.0035.0035.0034.00
  Goodwill0.2%1661661661661661651661661661598.008.008.008.008.008.007.008.008.008.008.00
Liabilities3.6%37736436637137234835834229028919018519115717618014713113293.0092.00
  Current Liabilities4.2%15114514414614513814613012311611210610878.0088.0091.0086.0070.0069.0066.0065.00
Shareholder's Equity6.8%1,1791,1041,0671,024999974970959954685650638620623488486467454437422409
  Retained Earnings67.2%13581.0071.0052.0044.0040.0042.0046.0046.0071.0052.0041.0037.0046.0058.0058.0048.0036.0020.009.002.00
  Additional Paid-In Capital1.6%1,0471,0311,001979963947938919911621603598585581436431423419420415408
Shares Outstanding0.9%39.0038.0038.0038.0038.0038.0038.0038.0038.0037.0036.00----------
Minority Interest-----------6.20-4.62-3.71-2.69-1.63-0.82-0.28-0.390.00-0.070.00-0.13
Float---12,700---4,500------6,000---5,100---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations17.6%36,26130,84417,09913,1291,337-12,909-39,575-4,514-9,27036,450-3,310-14,368-2,083-3,550-21,689-5,9204,76722,0501,903-2,0687,531
  Share Based Compensation-23.7%10,79114,13612,82312,7669,9979,7028,7868,89341,6627,9039,8036,3958,0556,2385,5595,6895,0146,2415,1355,0954,871
Cashflow From Investing154.7%24,280-44,396-6,67110,7118,6339,78620,66015,711-1,339-49,83126,3453,090-10,226-49,416-54,54410,037-43,73414,281-15,11331,8559,625
Cashflow From Financing2692.9%5,9212128,6941,3765,735-6039,131-2,6412,961-2,6843,173-2,6142,457-1,651138,461-4,350-502-1,439-5,308-1,7103,168

PEN Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenue$ 1,058,522$ 847,133$ 747,590
Cost of revenue375,879311,926272,208
Gross profit682,643535,207475,382
Operating expenses:   
Research and development84,42379,407104,552
Sales, general and administrative506,454449,718378,331
Acquired in-process research and development18,21500
Total operating expenses609,092529,125482,883
Income (loss) from operations73,5516,082(7,501)
Interest and other income (expense), net6,099(2,190)(3,001)
Income (loss) before income taxes79,6503,892(10,502)
(Benefit from) provision for income taxes(11,304)5,894(13,125)
Consolidated net income (loss)90,954(2,002)2,623
Net loss attributable to non-controlling interest00(2,661)
Net income (loss) attributable to Penumbra, Inc.$ 90,954$ (2,002)$ 5,284
Net income (loss) attributable to Penumbra, Inc. per share:   
Net income (loss) attributable to Penumbra, Inc. per share: Basic (in dollars per share)$ 2.37$ (0.05)$ 0.14
Net income (loss) attributable to Penumbra, Inc. per share: Diluted (in dollars per share)$ 2.32$ (0.05)$ 0.14
Weighted average shares outstanding:   
Weighted average shares outstanding: Basic (in shares)38,401,17137,841,87436,764,290
Weighted average shares outstanding: Diluted (in shares)39,216,56437,841,87437,881,180

PEN Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 167,486$ 69,858
Marketable investments121,701118,172
Accounts receivable, net of allowance for credit losses of $3,169 and $862 at December 31, 2023 and 2022, respectively201,768203,384
Inventories388,023334,006
Prepaid expenses and other current assets36,42430,279
Total current assets915,402755,699
Property and equipment, net72,69165,015
Operating lease right-of-use assets188,756192,636
Finance lease right-of-use assets31,09233,323
Intangible assets, net71,05681,161
Goodwill166,270166,046
Deferred taxes85,15864,213
Other non-current assets25,88012,793
Total assets1,556,3051,370,886
Current liabilities:  
Accounts payable27,15526,679
Accrued liabilities110,555106,300
Current operating lease liabilities11,20310,033
Current finance lease liabilities2,2311,920
Total current liabilities151,144144,932
Non-current operating lease liabilities197,229198,955
Non-current finance lease liabilities23,68024,865
Other non-current liabilities5,3083,276
Total liabilities377,361372,028
Commitments and contingencies
Stockholders’ equity:  
Preferred stock, $0.001 par value per share - 5,000,000 shares authorized, none issued and outstanding at December 31, 2023 and December 31, 202200
Common stock, $0.001 par value per share - 300,000,000 shares authorized, 38,681,549 issued and outstanding at December 31, 2023; 300,000,000 shares authorized, 38,107,977 issued and outstanding at December 31, 20223938
Additional paid-in capital1,047,198963,040
Accumulated other comprehensive loss(3,151)(8,124)
Retained earnings134,85843,904
Total stockholders’ equity1,178,944998,858
Total liabilities and stockholders’ equity$ 1,556,305$ 1,370,886
PEN
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
 CEO
 WEBSITEpenumbrainc.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES3900

Penumbra Inc Frequently Asked Questions


What is the ticker symbol for Penumbra Inc? What does PEN stand for in stocks?

PEN is the stock ticker symbol of Penumbra Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Penumbra Inc (PEN)?

As of Tue Apr 16 2024, market cap of Penumbra Inc is 8.13 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers. The fair value of Penumbra Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Penumbra Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PEN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Penumbra Inc a good stock to buy?

The fair value guage provides a quick view whether PEN is over valued or under valued. Whether Penumbra Inc is cheap or expensive depends on the assumptions which impact Penumbra Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PEN.

What is Penumbra Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, PEN's PE ratio (Price to Earnings) is 89.37 and Price to Sales (PS) ratio is 7.68. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PEN PE ratio will change depending on the future growth rate expectations of investors.